Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |